Differences in the Ratios of Morphine to Methadone in Patients with Neuropathic Pain Versus Non-Neuropathic Pain
Authors:
- Eduardo BrueraEBEduardo Bruera
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 18 (2) , 120-125
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dose ratio between morphine and methadone in patients with cancer painCancer, 1998
- Pharmacologic Treatment of Cancer PainNew England Journal of Medicine, 1996
- Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromorphone, and morphineCancer, 1996
- NONOPIOID AND OPIOID ANALGESIC PHARMACOTHERAPY OF CANCER PAINHematology/Oncology Clinics of North America, 1996
- Mechanisms of hyperalgesian and morphine tolerance: a current view of their possible interactionsPain, 1995
- Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cordNeuroscience Letters, 1995
- Methadone in the management of cancer pain: a reviewPain, 1993
- Custom-made suppositories of methadone for severe cancer painJournal of Pain and Symptom Management, 1992
- The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusionsPain, 1990
- The Treatment of Cancer PainNew England Journal of Medicine, 1985